USFDA Issues Form 483 With 11 Observations to Aurobindo Raleigh Plant
Aurobindo Pharma has announced that the US Food and Drug Administration (USFDA) issued a Form 483 with 11 observations to its Raleigh plant in North Carolina, operated by its subsidiary Aurolife Pharma LLC. The inspection was conducted from March 24 to April 10, 2025.
The observations are described as procedural and will be addressed through a comprehensive response within the required timeline, detailing corrective and preventive actions. Aurobindo emphasized its commitment to maintaining high-quality standards and stated that this development is not expected to impact current business operations or existing supplies from the facility.
This regulatory update highlights the importance of compliance in pharmaceutical manufacturing, with Aurobindo affirming its dedication to meeting USFDA standards.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-08-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA and NIH Launch a New Nutrition Science Partnership
-
FDA Sharpens the Dietary Supplement Ingredient Debate
-
FDA Reopens the Raw Manure Debate
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
EFSA’s Updated Food-Additive Application Guidance Takes Effect
-
India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs
-
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2
Recommend Reading
-
![China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026]()
China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026
-
![关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals]()
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
![EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation]()
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
![U.S. Imposes 12.5% Additional Tariff! Nutritional Ingredients Including Creatine, Taurine, and Glucosamine Included in New Section 301 Tariff List]()
U.S. Imposes 12.5% Additional Tariff! Nutritional Ingredients Including Creatine, Taurine, and Glucosamine Included in New Section 301 Tariff List
-
![FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions]()
FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
-
![Dodecyl Acid: Industrial Uses and Chemical Characteristics]()
Dodecyl Acid: Industrial Uses and Chemical Characteristics
-
![Supply Contraction Keeps Raw Materials Firm; PP Market Prices Remain High and Continue to Rise]()
Supply Contraction Keeps Raw Materials Firm; PP Market Prices Remain High and Continue to Rise
-
![Weak Supply and Demand Fundamentals Lead to Weak Polyethylene Market Performance]()
Weak Supply and Demand Fundamentals Lead to Weak Polyethylene Market Performance
-
![Ammonia Chemical Formula: NH3 Structure & Properties]()
Ammonia Chemical Formula: NH3 Structure & Properties
-
![Benzyl Alcohol: Uses in Cosmetics, Preservative Efficacy, and Safety]()
Benzyl Alcohol: Uses in Cosmetics, Preservative Efficacy, and Safety
